Has Cochrane lost its way?

@article{Newman2019HasCL,
  title={Has Cochrane lost its way?},
  author={Melanie Newman},
  journal={British Medical Journal},
  year={2019},
  volume={364}
}
  • M. Newman
  • Published 2019
  • Medicine
  • British Medical Journal
Dissent over growing centralisation culminated in the expulsion of one of Cochrane’s founding members. Melanie Newman reports on the organisation’s internal struggles 
Clarification of News Feature “Has Cochrane lost its way?”
Tovey claims that the statement in my piece that Cochrane guidance “still allows reviewers to review their own studies” is an “error” and that Cochrane guidance does not allow this.12 He says,Expand
Cochrane has not consistently followed the COPE guidelines
  • H. Hemilä
  • Medicine, Political Science
  • European journal of clinical investigation
  • 2020
There have been concerns about the procedures and policies of the Cochrane organization. Here I describe one case where Cochrane procedures seemed inconsistent with the Committee on PublicationExpand
David Tovey replies to Melanie Newman and The BMJ
  • D. Tovey
  • Medicine, Political Science
  • BMJ
  • 2019
Newman asks whether Cochrane has “lost its way” given recent ructions arising from the governing board’s decision to remove membership status from Peter Gotzsche.1 On the contrary, by all objectiveExpand
Quo Vadis, Cochrane Collaboration?
  • A. Jokstad
  • Medicine
  • Clinical and experimental dental research
  • 2019
TLDR
It seems to undersigned that this initially idealistic charity has contracted some form of Icarus syndrome prompted by seduction to generate substantial revenues rather than strengthening the actual value of the offered products. Expand
Expelled Cochrane director to set up new institute for “integrity in science”
  • M. Newman
  • Political Science, Medicine
  • British Medical Journal
  • 2019
TLDR
The expelled member of Cochrane’s board Peter Gotzsche plans to found a new Institute for Scientific Freedom, which will focus on lobbying for improvements in healthcare research quality as well as producing its own research. Expand

References

SHOWING 1-10 OF 14 REFERENCES
New CEO transforming The Cochrane Collaboration
  • N. Chanchlani
  • Computer Science, Medicine
  • Canadian Medical Association Journal
  • 2013
TLDR
The Cochrane Collaboration offices are small; standing outside their modestly sized single-floor office makes you wonder just how they wield such clout. Expand
Cochrane at crossroads over drug company sponsorship
TLDR
The Cochrane Collaboration is at a crossroads, with its supporters deeply divided over whether to embrace drug company sponsorship, and delegates to its annual colloquium next week will debate the thorny question of conflict of interest. Expand
New Cochrane policy tightens limits on industry funding
  • J. Lenzer
  • Medicine
  • BMJ : British Medical Journal
  • 2004
TLDR
A year long struggle over funding of the Cochrane Collaboration has been settled: a policy just issued by the organisation will limit industry funding, reflecting the overwhelming consensus of members. Expand
Neuraminidase inhibitors—the story behind the Cochrane review
  • P. Doshi
  • Medicine
  • BMJ : British Medical Journal
  • 2009
Although billions have been spent on oseltamivir in the face of pandemic influenza, the team updating the Cochrane review of neuraminidase inhibitors in healthy adults found that the public evidenceExpand
Evidence-based medicine and the Cochrane Collaboration on trial.
  • D. Cundiff
  • Medicine
  • MedGenMed : Medscape general medicine
  • 2007
TLDR
The Cochrane Collaboration was founded in 1993 and was named for the British epidemiologist Archie Cochrane, MD (1908-1988), who suggested that the free care in the National Health Service should be limited to interventions supported by evidence of their effectiveness. Expand
Research synthesis and dissemination as a bridge to knowledge management: the Cochrane Collaboration.
TLDR
The work of the Cochrane Collaboration is set in historical perspective, what a Cochrane review is, initiatives for promoting worldwide dissemination of synthesized information are described, and the need for increased investment in the preparation and maintenance of Cochrane reviews is highlighted. Expand
Quality of Cochrane reviews: assessment of sample from 1998
TLDR
Too often, reviewers' conclusions over-rated the benefits of new interventions and readers of Cochrane reviews should remain cautious, especially regarding conclusions that favour new interventions. Expand
Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare
TLDR
Busting the industry myths, the business model of big pharma, Psychiatrists as drug pushers and more lies about happy pills are revealed. Expand
Why I think antidepressants cause more harm than good.
TLDR
A systematic review of 21 trials in a variety of diseases that had both masked and non-masked outcome assessors, and which had mostly used subjective outcomes, found that the treatment effect was exaggerated by 36% on average when non- masked observers rather than masked ones assessed the effect. Expand
Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study
TLDR
Most Cochrane reviews of drug trials published in 2010 did not provide information on trial funding sources or trial author-industry financial ties or employment, and location of reporting was inconsistent across reviews. Expand
...
1
2
...